Skip to search formSkip to main contentSkip to account menu

BM 613

Known as: BM-613, BM613 cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist
2004
2004
In vivo evaluation of antithrombotic potency of BM-613, a thromboxane A2 receptor antagonist, in a rat model of arterial thrombosis
2003
2003
Pharmacological evaluation of the thromboxane A2 receptor antagonist BM-613
2003
2003
Synthesis and pharmacological evaluation of BM-613, an original thromboxane A2 antagonist
2003
2003
BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)